Dilip Shanghvi
Dilip Shanghvi | Founder and Managing Director, Sun Pharmaceutical Industries | $25.1B as of 6/30/24
Dilip Shanghvi is an Indian billionaire businessman, best known as the founder of Sun Pharmaceuticals, the largest pharmaceutical company in India and among the top generic drug makers in the world. His strategic vision and leadership have made significant impacts on the pharmaceutical industry globally.
Personal Information:
Full Name: Dilip Shantilal Shanghvi
Name in the Language of Origin: दिलीप शांतीलाल शांघवी
Date of Birth: October 1, 1955
Place of Birth: Amreli, Gujarat, India
Zodiac: Libra
Marital Status and Family:
Spouse: Vibha Shanghvi
Children: Two, Aalok Shanghvi and Vidhi Shanghvi
Relatives:
Father: Shantilal Shanghvi
Mother: Kumud Shanghvi
Background and Early Life:
Family Background:
Born into a Jain family, his father was a pharmaceutical distributor. The family background in pharmaceuticals played a significant role in shaping his career.
Ancestry:
Jain family from Gujarat, India.
Early Influences:
His father's business in pharmaceuticals influenced his career choice.
Influential Figures:
His father, Shantilal Shanghvi
Books That Impacted the Most:
Specific books are not publicly known.
Educational Background:
Education:
Bachelor of Commerce degree from the University of Calcutta.
Professional Career:
Current Occupation:
Managing Director of Sun Pharmaceuticals
Career History:
In 1982, the 27-year-old Shanghvi finally opened his first manufacturing unit with a capital of INR 10,000. He named his venture Sun Pharmaceutical Industries. The unit, located in Vapi in his native state of Gujarat, a short drive away from Mumbai, produced exactly one psychiatry drug. However, the business soon picked up, thanks to Shanghvi's acumen and energy, and by 1997, Sun Pharma was even able to acquire Caraco Pharma, an American company. Sun also acquired Israel's Taro Pharma in 2007.
Shanghvi stepped down as chairman and CEO in 2012 and chose Israel Makov, formerly CEO of Teva Pharmaceuticals, as his successor; Shanghvi became managing director.
In May 2021 he stepped down from the position of Managing director of SPARC and will continue to function as a non-executive director and chairman
Career Milestones:
Key Achievements:
Grew Sun Pharmaceuticals to become the largest pharmaceutical company in India and among the top globally.
Successful acquisition of Ranbaxy Laboratories in 2014, making Sun Pharma the largest pharma company in India.
Innovations and Contributions:
Focus on niche markets and specialty generics.
Expansion through strategic acquisitions.
Industry Impact:
Significant influence on the global generic drug market.
Net Worth and Assets:
Estimated Net Worth: Approximately $13.5 billion (as of 2023) .
Key Assets: Major holdings in Sun Pharmaceuticals.
Investments: Diversified investments through various ventures.
Stock Records: Significant holdings in Sun Pharmaceuticals (NSE: SUNPHARMA).
Business Interests:
Primary Business: Pharmaceuticals
Known Current and Past Board of Directors Positions:
Director, Sun Pharmaceuticals.
In January 2018, the Indian government appointed Shanghvi to the Reserve Bank of India's 21-member central board committee.
He is chairman of the board of governors at IIT Bombay.
He was made a trustee of the Rhodes scholarship programme at Oxford University in 2017.
Other Ventures:
Taro Pharmaceutical Industries
Ranbaxy Laboratories
Sun Pharma Advanced Research Company (SPARC)
Leadership Style and Business Philosophy:
Leadership Approach: Visionary, strategic, and growth-focused.
Business Philosophy: Emphasizes innovation, strategic acquisitions, and market expansion.
Philanthropy and Social Contributions:
Charitable Donations:
Significant contributions to healthcare and education sectors.
Foundations and Initiatives:
Involved in various philanthropic activities through family foundations.
Philanthropic Goals: Improving healthcare access and educational opportunities.
Environmental Stewardship: Supports sustainable practices within his business ventures.
CSR: Emphasizes corporate social responsibility through Sun Pharmaceuticals' initiatives.
Lifestyle and Interests:
Main Residence: Mumbai, Maharashtra, India.
Personal Values: Family, education, and healthcare.
Hobbies and Interests: Reading, traveling.
Social Circles:
Business and philanthropic circles in India.
Membership in Private Clubs and Social Organizations:
Specific memberships are not widely publicized.
Associates:
Business Connections:
Israel Makov: Chairman of Sun Pharmaceuticals.
Dinesh Patel: Former CEO of Sun Pharmaceuticals.
Aalok Shanghvi: Son and senior executive at Sun Pharmaceuticals.
Vidhi Shanghvi: Daughter and involved in family business.
Rashmi Barbhaiya: CEO of SPARC.
Kal Sundaram: Senior executive at Sun Pharmaceuticals.
Abhay Gandhi: CEO of North America business, Sun Pharmaceuticals.
Dilip Sinha: Board member of Sun Pharmaceuticals.
Pawan Goenka: Independent Director at Sun Pharmaceuticals.
Sudhir Valia: Executive Director at Sun Pharmaceuticals.
Personal Connections:
Vibha Shanghvi: Wife.
Aalok Shanghvi: Son.
Vidhi Shanghvi: Daughter.
Shantilal Shanghvi: Father.
Kumud Shanghvi: Mother.
Samprada Singh: Mentor and founder of Alkem Laboratories.
Yashwant Mahadik: Family friend and HR executive.
Pramod Maheshwari: Educational philanthropist and associate.
Harsha Vardhan Agarwal: Family business associate.
Kiran Mazumdar-Shaw: Professional acquaintance, Biocon.
Dr. Reddy's: Business associate in pharmaceuticals.
Narayana Murthy: Personal acquaintance, Infosys.
Azim Premji: Philanthropic partner, Wipro.
Ratan Tata: Business acquaintance, Tata Group.
Mukesh Ambani: Business acquaintance, Reliance Industries.
Adam Schechter: Chairman, president, and CEO of Labcorp
Political and Social Influence:
Political Affiliations: Maintains a low political profile, but supports pro-business policies.
Advocacy: Advocates for better healthcare policies and access.
Significant Political Statements: Generally aligned with business-friendly policies.
Future Plans and Projects:
Upcoming Ventures: Continued expansion of Sun Pharmaceuticals.
Forecasts: Focus on innovation in pharmaceuticals and expansion in global markets.
Legacy: Known for transforming Sun Pharmaceuticals into a global powerhouse.
Available Data on Possessions:
Yachts: Not publicly known.
Private Jets: Likely uses corporate jets from Sun Pharmaceuticals.
Cars: Known for a preference for luxury vehicles, specifics not publicly disclosed.
Art: Not widely known for art collections.
Real Estate and Residences: Properties in Mumbai and possibly other locations, specifics not widely publicized.
Collectables: Not widely known for collectible items.
Expensive Accessories: Prefers a low-profile lifestyle, limited public information on luxury accessories.
Public Persona and Influence:
Media Presence: Low-profile, primarily business-related mentions.
Public Speaking: Rarely participates in public speaking engagements.
Public Appearances:
Annual general meetings of Sun Pharmaceuticals
Industry conferences
Philanthropic events
Healthcare summits
Educational fundraisers
Business forums
Community development events
Private business gatherings
Exclusive social functions
Industry award ceremonies
Recognition and Awards:
Forbes' list of billionaires.
India Today magazine ranked him 8th in India's most powerful people of 2017 list.
The Government of India awarded him the civilian honor of the Padma Shri in 2016.
Future Plans and Projects:
Upcoming Ventures: Continued focus on expanding Sun Pharmaceuticals' global footprint.
Forecasts: Expected to maintain leadership in the pharmaceutical industry.
Legacy: Remembered for his significant contributions to the pharmaceutical industry and his philanthropic efforts.
Political and Social Influence:
Political Affiliations: Supports pro-business policies.
Advocacy: Advocates for better healthcare access and policies.
Significant Political Statements: Supports policies that benefit the pharmaceutical industry.
Other Information:
Unique Contributions: Significant impact on the global pharmaceutical industry and notable philanthropic contributions.
Media Search Results for Dilip Shanghvi
Here are some biographical books that mention Dilip Shanghvi:
"The Reluctant Billionaire: How Dilip Shanghvi Became the Richest Self-Made Indian" by Soma Das. This book provides an in-depth look at Shanghvi's journey, based on extensive interviews with his friends, family, and colleagues (MoneyControl).
Controversies and Legal Issues
Controversies
Dilip Shanghvi has faced criticism for aggressive business tactics, particularly concerning acquisitions and market strategies of Sun Pharmaceuticals. These tactics have sometimes raised eyebrows in the pharmaceutical industry for their intensity and impact on competitors.
Legal Issues
Shanghvi and Sun Pharmaceuticals have been involved in several legal issues, including a notable case where the U.S. FDA raised concerns about compliance and quality control at some of Sun Pharma's manufacturing facilities. These issues have led to import bans and other regulatory actions in the past.
Scandals
No significant personal scandals involving Dilip Shanghvi have been reported. Most issues are related to the business practices of Sun Pharmaceuticals and their regulatory challenges.
Allegations
Sun Pharmaceuticals has faced allegations related to price fixing and anticompetitive practices. These allegations have been investigated by regulatory bodies in various countries, impacting the company's reputation and operations.
Criticisms
Critics often point to the opaque nature of some of Shanghvi's business dealings and the aggressive expansion strategies of Sun Pharmaceuticals, which have occasionally led to regulatory scrutiny and legal challenges.
Public Conflicts
Shanghvi has generally maintained a low profile and avoids public conflicts. However, his company has had disputes with competitors and regulatory bodies over business practices and compliance issues.
Curious Information
Little-known Biography Facts
Dilip Shanghvi started his career by helping his father in his wholesale generic drugs business before founding Sun Pharmaceuticals.
Despite his immense success in pharmaceuticals, Shanghvi does not have a formal degree in science or pharmacy.
Unusual Experience
Shanghvi once topped Mukesh Ambani as India's richest person in 2015, a significant milestone in his career that brought him widespread attention and scrutiny (MoneyControl).
Shanghvi is a devotee of Shrinathji and makes regular pilgrimage with his family to the deity's abode in the city of Nathdwara in Rajasthan. Photos and idols of the deity adore Sun Pharma's factory and offices.
Gossip and Rumors
There are relatively few rumors about Shanghvi due to his low-key and private nature. His business practices, however, often stir conversations in industry circles.
Mentions in Conspiracy Theories
Dilip Shanghvi is not commonly mentioned in conspiracy theories. His public image is primarily associated with his business achievements and strategic acumen in the pharmaceutical industry.
Psycho-Emotional Profile of Dilip Shanghvi
Emotional State and Mood
Dilip Shanghvi, the founder and managing director of Sun Pharmaceutical Industries, generally presents a calm and composed demeanor. His public appearances and business decisions suggest a stable emotional state, characterized by determination and optimism. Shanghvi’s predominant emotions are likely confidence and perseverance, which have been essential in his journey from modest beginnings to becoming one of India’s richest individuals.
Personality Traits
Shanghvi exhibits key personality traits such as conscientiousness, introversion, and resilience. His conscientious nature is evident in his meticulous and strategic approach to business, particularly in building Sun Pharma into a global pharmaceutical powerhouse. Despite his significant public influence, Shanghvi maintains a relatively low profile, reflecting introverted tendencies. His resilience is demonstrated by his ability to steer Sun Pharma through various challenges, including significant acquisitions and market competition.
Stress Levels and Coping Mechanisms
Given his leadership role and the competitive nature of the pharmaceutical industry, Shanghvi likely experiences considerable stress. However, he manages this stress through strategic planning, problem-solving, and a strong support network. His focus on long-term goals and consistent business growth indicates effective coping mechanisms. Shanghvi’s ability to remain composed during market fluctuations and corporate challenges suggests that he employs rational analysis and decisive action to mitigate stress.
Self-Esteem and Self-Concept
Shanghvi’s self-esteem appears high, bolstered by his substantial achievements and the respect he commands in the industry. He likely views himself as a capable and influential leader, a perception reinforced by his successful management of Sun Pharma and his strategic investments in various sectors. His self-concept is closely tied to his identity as a successful entrepreneur and a key figure in the global pharmaceutical market.
Interpersonal Relationships
Shanghvi maintains strong professional relationships within Sun Pharma and the broader business community. His leadership style fosters loyalty and respect among his employees and business partners. On a personal level, his relationships are supported by a close-knit network, contributing to his emotional and psychological stability. Shanghvi’s ability to build and sustain these relationships highlights his interpersonal skills and emotional intelligence.
Behavioral Patterns
Shanghvi’s behavior is characterized by disciplined, goal-oriented actions. His business practices demonstrate a pattern of calculated risk-taking and meticulous execution, essential for expanding Sun Pharma’s capabilities and market reach. His methodical approach to business and investment decisions suggests a structured and organized lifestyle focused on long-term success. There are no public indications of maladaptive behaviors, reinforcing the perception of a well-regulated personal and professional life.
Psychological Well-being
Overall, Shanghvi’s psychological well-being appears robust. His ability to handle significant business challenges while maintaining a positive outlook contributes to high life satisfaction. Despite the pressures associated with his roles, there are no signs of significant mental health issues, indicating a stable psychological state and a positive perspective on his professional and personal life.
Cognitive Functioning
Shanghvi’s cognitive abilities are exceptional, evidenced by his strategic thinking and problem-solving skills. His successful navigation of complex business environments and anticipation of industry trends showcase strong memory, attention, and analytical capabilities. His innovative approach to pharmaceutical production and market expansion reflects a sharp and strategic mind.
Past Experiences and Trauma
Shanghvi’s experiences, including his rise in the pharmaceutical industry and his leadership of Sun Pharma, have shaped his resilient and strategic nature. These experiences have contributed to his robust coping mechanisms and his ability to focus on long-term objectives despite facing substantial challenges and market volatility.
Motivations and Goals
Shanghvi is driven by a desire to innovate and lead in the pharmaceutical industry. His personal goals include expanding Sun Pharma’s global influence and continuing to drive technological advancements in medicine. Both intrinsic motivations, such as personal fulfillment from business success, and extrinsic motivators, like financial gain and industry recognition, drive his actions.
Physical Health and Its Impact
There is limited public information on Shanghvi’s physical health, but his active involvement in professional activities suggests he maintains good physical well-being. His physical health supports his ability to manage his responsibilities effectively, contributing to his overall psychological resilience.
Conclusion
Dilip Shanghvi’s psycho-emotional profile portrays him as a resilient, conscientious, and strategic leader. His strong self-concept, effective stress management, and robust psychological well-being enable his continuous success in the pharmaceutical industry. His personality traits, cognitive abilities, and motivations align to create a profile of a highly driven and impactful figure in the global business landscape.
Content Interaction Guide for Informed Users
At UHNWI Direct, we value the collective wisdom and expertise of our community in maintaining the highest standards of accuracy and transparency. Your contributions play a pivotal role in enriching our profiles with up-to-date and reliable information. By sharing your insights, knowledge, and analytical skills, you not only enhance the quality of our content but also contribute to a more informed global community.
Your deep understanding of specific industries, nuanced perspectives, and firsthand experiences can illuminate aspects of our profiles that might otherwise remain obscure. Whether you identify an error that needs correction, provide additional context that enriches the digital footprint, or validate key details through credible sources, your involvement strengthens the integrity of the information we provide.
At the heart of our mission is a commitment to transparency and correctness. By participating in fact-checking processes and contributing verified information, you empower readers and stakeholders to make informed decisions based on reliable data. Your intellectual engagement and dedication to accuracy are crucial in shaping a platform that is trusted for its depth and authenticity.
Join us in our pursuit of excellence by sharing your expertise and helping us uphold the highest standards of integrity in information dissemination. Together, we can foster a community where knowledge is celebrated, accuracy is paramount, and transparency is upheld as a cornerstone of our values. Your contributions matter—they shape the narrative, empower decision-making, and ensure that UHNWI Direct remains a beacon of reliability in a world hungry for trustworthy information.
Get in touch with Dilip Shanghvi
Join UHNWI direct Affiliate Program
Earn Passive Income by Sharing Verified Contact Information of Billionaires, Centi-Millionaires, and Multi-Millionaires on the UHNWI Direct Platform
Maximize your earnings potential by sharing direct and validated contact information of the ultra-wealthy, including billionaires, centi-millionaires, and multi-millionaires. Join the UHNWI Direct platform and tap into a lucrative passive income stream by providing valuable data to those seeking high-net-worth connections. Start earning today with UHNWI Direct.
You may also be interested in reviewing other UHNWIs profiles.
To find the person you want to contact, start typing their name or other relevant tags in the search bar.
Please note: Our database contains over 10,000 direct contacts of UHNWIs, and it is highly likely that the individual you are seeking is already included. However, creating individual profiles for each contact is a meticulous and time-intensive process, So, if you are unable to find the profile of the individual you are looking for, please click here.
Filter by Net Worth: All | Billionaires | Centi-Millionaires | Multi-Millionaires
Filter by Location: All | USA | Canada | Europe | UK | Russia & CIS | Asia | MEIA | Australia | Latin America
Filter by Age: 1920-1930 | 1930-1940 | 1940-1950 | 1950-1960 | 1960-1970 | 1970-1980 | 1980-1990 | 1990-2000
Related People
